This journal uses ScholarOne Manuscripts (previously Manuscript Central) to peer review manuscript submissions. Please read the guide for ScholarOne authors before making a submission. Complete guidelines for preparing and submitting your manuscript to this journal are provided below.

The instructions below are specifically directed at authors that wish to submit a manuscript to Psychosis. For general information, please visit our Author Services.

Psychosis considers all manuscripts on the strict condition that they have been submitted only to Psychosis, that they have not been published already, nor are they under consideration for publication or in press elsewhere. Authors who fail to adhere to this condition will be charged with all costs which Psychosis incurs and their papers will not be published.

Contributions to Psychosis, whether research papers, reviews, or first person accounts (from service users or therapists), will be subjected to peer review by referees at the discretion of the Editorial Office.

Manuscript preparation

1. General guidelines

• Manuscripts should be consistent with the Aims and Scope of the journal.
• Papers are accepted only in English. American or British English spelling and punctuation is preferred provided usage is consistent throughout.
• The following word limits apply (including the abstract, tables, figures, and references):
  Research articles and reviews will not exceed 5,000 words;
  First person accounts (both kinds) 3,500 words;
  Brief Report - 1,000 words;
  Opinion Pieces - 1,000 words;
  Letters to Editor - 400 words;
  Book Reviews - 1,000 words.

Please do not submit Abstracts for Letters to Editor or  Book Reviews.   

• Submitted manuscripts should be anonymised to allow for review. A separate title page should be submitted containing the author name. 
• Manuscript should be assembled in the following order: main text; acknowledgements; appendixes (as appropriate); references; table(s) with caption(s) (on individual pages).
• A separate Abstracts of 200 words (100 words for First person accounts and Opinion Pieces) should also be provided for review papers, research papers and brief reports.
• Each paper should have up to five keywords.
• Section headings should be concise.
• Please include, in the Discussion section, a subsection subtitled Clinical Implications (or Practical Implications if you see implications beyond mental health services, eg primary prevention).
• For all manuscripts non-discriminatory language is mandatory. Sexist or racist terms should not be used.
• Authors must adhere to SI units. Units are not italicised.
• When using a word which is or is asserted to be a proprietary term or trade mark, authors must use the symbol ® or TM.
• Authors are encouraged to identify at least one 'preferred reviewer' when submitting. 

2. Style guidelines

• Desription of the Journal's article style, Quick guide
• Description of the Journal's reference style, Quick guide. Visit CiteRefs for assistance in ensuring accurate referencing according to APA style.

Word templates
Word templates are available for this journal. If you are not able to use the template via the links or if you have any other template queries, please contact authortemplate@tandf.co.uk (please mention the journal title in your email).

3. Figures

We welcome figures sent electronically, but care and attention to these guidelines are essential as importing graphics packages can often be problematic.

• Please be sure that all imported scanned material is scanned at the appropriate resolution: 1200 dpi for line art, 600 dpi for grayscale and 300 dpi for colour.
• Figures must be saved individually and separate to text. Please do not embed figures in the paper file.
• Avoid the use of colour and tints for purely aesthetic reasons.
• Figures should be produced as near to the finished size as possible.
• All figures must be numbered in the order in which they appear in the paper (e.g. figure 1, figure 2). In multi-part figures, each part should be labelled (e.g. figure 1(a), figure 1(b)).
• Figure captions must be saved separately, as part of the file containing the complete text of the paper, and numbered correspondingly.
• The filename for the graphic should be descriptive of the graphic, e.g. Figure1, Figure2a.
• Files should be saved as one of the following formats: TIFF (tagged image file format), PostScript or EPS (encapsulated PostScript), and should contain all the necessary font information and the source file of the application (e.g. CorelDraw/Mac, CorelDraw/PC).

Please note that it is in the author's interest to provide the highest quality figure format possible. Please do not hesitate to contact our Production Department if you have any queries.

4. Tables

Tables should be numbered consecutively with Arabic numbers in order of appearance in the text. Type each table double-spaced on a separate page, with a short descriptive title typed directly above and with essential footnotes below.

5. Reproduction of copyright material

Contributors are required to secure permission for the reproduction of any figure, table or extensive extract (more than fifty words) from the text of a source that is copyrighted or owned by a party other than Taylor & Francis or the contributor. This applies to direct reproduction as well as 'derivative reproduction', where the contributor has created a new figure or table that derives substantially from a copyrighted source. Authors are themselves responsible for the payment of any permission fees required by the copyright owner. Copies of permission letters should be sent with the manuscript upon submission to the Editor(s).

• Copyright permission letter template
  6. Informed consent
  
  Manuscripts must include a statement that informed consent was obtained from human subjects. Authors should protect patient anonymity by avoiding the use of patients' names or initials, hospital number, or other identifying information.

7. Code of experimental ethics and practice and confidentiality

Contributors are required to follow the procedures in force in their countries which govern the ethics of work conducted with human or animal subjects. The Code of Ethics of the World Medical Association (Declaration of Helsinki) represents a minimal requirement.

For human subjects or patients, describe their characteristics. For human participants in a research survey, secure the consent for data and other material - verbatim quotations from interviews, etc. - to be used. Specific permission for any facial photographs is required. A letter of consent must accompany any photographs in which the possibility of identification exists. It is not sufficient to cover the eyes to mask identity.

It is your responsibility to ensure that the confidentiality of patients is maintained. All clinical material used in your article must be disguised so that it is not recognisable by a third party. Where possible and appropriate, the permission of the patient should be obtained. Authors are invited to discuss these matters with the editor if they wish.

8. Drug names

Generic rather than trade names of drugs should be used, although trade names may be mentioned in parentheses in the first text reference to the drug.

9. Competing financial interests

A competing interest exists when your interpretation or presentation of information may be influenced by your personal or financial relationship with other people or organizations. Authors should disclose all financial and non-financial competing interests.

Authors are required to complete a declaration of competing interests and submit it together with the manuscript. All competing interests that are declared will be listed at the end of published articles. Where an author gives no competing interests, the listing will read 'The author(s) declare that they have no competing interests'. Please consider the following questions:

1. In the past five years have you received reimbursements, fees, funding, or salary from an organization that may in any way gain or lose financially from the publication of this manuscript, either now or in the future? Is such an organization financing this manuscript? If so, please specify.
2. Do you hold any stocks or shares in an organization that may in any way gain or lose financially from the publication of this manuscript, either now or in the future? If so, please specify.
3. Do you hold or are you currently applying for any patents relating to the content of the manuscript? Have you received reimbursements, fees, funding, or salary from an organization that holds or has applied for patents relating to the content of the manuscript? If so, please specify.
4. Do you have any other financial competing interests? If so, please specify.

If you are unsure as to whether you, or one of your co-authors, has a competing interest please discuss it with the editorial office.

As an author, you are required to secure permission if you want to reproduce any figure, table, or extract from the text of another source. This applies to direct reproduction as well as "derivative reproduction" (where you have created a new figure or table which derives substantially from a copyrighted source). For further information and FAQs, please see http://journalauthors.tandf.co.uk/preparation/permission.asp.   

Exceptions are made for Government employees whose policies require that copyright cannot be transferred to other parties. We ask that a signed statement to this effect is submitted when returning proofs for accepted papers.  

Page charges

Visit our Author Services website for further resources and guides to the complete publication process and beyond.